Medicinal Products Reimbursement

Dáil Éireann Debate, Friday - 6 September 2019

Friday, 6 September 2019

Questions (1285)

Lisa Chambers

Question:

1285. Deputy Lisa Chambers asked the Minister for Health the reason for the delay in reimbursing the drug levodopa-carbidopa intestinal gel known as duodopa; when a decision will be made regarding reimbursement; and if he will make a statement on the matter. [36493/19]

Written answers

Minister for Health

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.